Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Proton-linked monocarboxylate transporter. Zusätzlich bieten wir Ihnen SLC16A4 Proteine (4) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 17 products:
This study showed that mouse MCT1 (zeige MCTS1 Antikörper), MCT2 (zeige SLC16A7 Antikörper), and MCT4 (zeige SLC16A3 Antikörper) are expressed in the PNS. While DRG neurons express MCT1 (zeige MCTS1 Antikörper), myelinating Schwann cells.
Expression of cerebral MCT (zeige MCAT Antikörper) isoforms can be modulated by alterations of peripheral metabolism, suggesting that the adult brain is sensitive and adapts to new metabolic states.
MCT1 (zeige CMA1 Antikörper) inhibitor AZD3965 increased MCT4-dependent accumulation of intracellular lactate, inhibiting monocarboxylate influx and efflux.
The reversible H(+)/lactate(-) symporter MCT4 cotransports lactate and proton, leading to the net extrusion of lactic acid in glycolytic tumors. A model of its role in pH control in tumor cells is described. Review.
Increased miR (zeige MLXIP Antikörper)-210 and concomitant decreased ISCU (zeige ISCU Antikörper) RNA levels were found in ~40% of tumors and this was significantly associated with HIF-1alpha (zeige HIF1A Antikörper) and CAIX (zeige CA9 Antikörper), but not MCT1 (zeige CMA1 Antikörper) or MCT4, over-expression.
High expression of MCT4 is associated with inflammation in arsenite-induced liver carcinogenesis.
The loss expression of Cav-1 on CAFs and the up-regulation of MCT4 may be the possible mechanisms of CAFs in tumorigenesis.
MCT1 (zeige CMA1 Antikörper) and MCT4 expression levels were associated with worse prognosis and shorter overall survival.
We demonstrated that the expression levels of glycolysis-related proteins glucose transporter 1 (zeige SLC2A1 Antikörper), hexokinase II, carbonic anhydrase IX (zeige CA9 Antikörper), and monocarbonylate transporter 4 differ between thyroid cancer subtypes and are correlated with poorer prognosis
Data suggest that inhibition of mnocarboxylate transporters MCT1 (zeige CMA1 Antikörper) and MCT4 may have clinical relevance in pancreatic ductal adenocarcinoma (PDAC).
MCT1 (zeige CMA1 Antikörper) inhibition impairs proliferation of glycolytic breast cancer cells co-expressing MCT1 (zeige CMA1 Antikörper) and MCT4 via disruption of pyruvate rather than lactate export.
MCT1 (zeige CMA1 Antikörper) expression was not clearly associated with overall or disease-free survival. MCT4 and CD147 expression correlate with worse prognosis across many cancer types. These results warrant further investigation of these associations
Proton-linked monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate (By similarity).
solute carrier family 16, member 4 (monocarboxylic acid transporter 5)
, solute carrier family 16, member 4
, monocarboxylate transporter 5
, monocarboxylate transporter 6
, solute carrier family 16 member 5
, MCT 4
, MCT 5
, monocarboxylate transporter 4
, solute carrier family 16 (monocarboxylic acid transporters), member 4